mounjaro tirzepatide patent expiry us leads India obesity drug sales as generic semaglutide gains traction post In weight loss battle, Novo

GLP-1s may lower the risk of death in people with obesity, breast cancer Researchers also looked at how GLP-1s affect death in people with breast cancer and obesity who are on hormonal therapy

The true detection rate for hypoglycemia was 99.2%, while for hyperglycemia, the true detection rate was 97.5%

During a consultation, your provider at Injectco can help you determine if semaglutide is right for you

In animal-based models of depressive-like behavior, administration of the peptide was linked to attenuation of behavioral symptoms, indicating possible antidepressant-like activity under experimental conditions (25,26)

See updated 2026 data, side effects, and how Canadians can access it